Comment on "Risk of gastric cancer among long‑term proton pump inhibitor users: a population‑based cohort study"
Eur J Clin Pharmacol
.
2024 Apr;80(4):621-622.
doi: 10.1007/s00228-024-03636-2.
Epub 2024 Jan 31.
Authors
Shih-Wei Lai
1
2
,
Bing-Fang Hwang
3
,
Chiu-Shong Liu
1
2
,
Kuan-Fu Liao
4
5
Affiliations
1
Department of Medicine, College of Medicine, China Medical University, Taichung, Taiwan.
2
Department of Family Medicine, China Medical University Hospital, Taichung, Taiwan.
3
Department of Occupational Safety and Health, College of Public Health, China Medical University, Taichung, Taiwan.
4
College of Medicine, Tzu Chi University, Hualien City, Taiwan. kuanfuliaog@gmail.com.
5
Division of Hepatogastroenterology, Department of Internal Medicine, Taichung Tzu Chi Hospital, Taichung, Taiwan. kuanfuliaog@gmail.com.
PMID:
38294552
DOI:
10.1007/s00228-024-03636-2
No abstract available
Publication types
Letter
MeSH terms
Cohort Studies
Histamine H2 Antagonists
Humans
Proton Pump Inhibitors*
Risk Factors
Stomach Neoplasms*
Substances
Proton Pump Inhibitors
Histamine H2 Antagonists